Burning Rock Biotech [BNR] vs Danaher [DHR] Detailed Stock Comparison

Burning Rock Biotech Ltd.

NASDAQ
Loading...

Danaher Corporation

NYSE
Loading...

TLDR: Quick Comparison Summary

Based on 21 vital metrics comparison: Burning Rock Biotech Ltd. wins in 7 metrics, Danaher Corporation wins in 11 metrics, with 0 ties. Danaher Corporation appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Burning Rock Biotech Ltd. Danaher Corporation Better
P/E Ratio (TTM) -0.61 34.61 Danaher Corporation
Price-to-Book Ratio 2.76 2.40 Danaher Corporation
Debt-to-Equity Ratio 8.06 37.17 Burning Rock Biotech Ltd.
PEG Ratio 0.01 3.84 Burning Rock Biotech Ltd.
EV/EBITDA -499.77 17.69 Danaher Corporation
Profit Margin (TTM) -10.26% 14.89% Danaher Corporation
Operating Margin (TTM) -9.53% 22.94% Danaher Corporation
EBITDA Margin (TTM) N/A 22.94% N/A
Return on Equity -9.92% 7.08% Danaher Corporation
Return on Assets (TTM) -4.02% 4.19% Danaher Corporation
Free Cash Flow (TTM) $-98.24M $5.26B Danaher Corporation
Dividend Yield N/A 0.56% N/A
1-Year Return 200.65% -3.81% Burning Rock Biotech Ltd.
Price-to-Sales Ratio (TTM) 0.41 5.10 Burning Rock Biotech Ltd.
Enterprise Value $253.48M $140.38B Danaher Corporation
EV/Revenue Ratio 3.20 5.67 Burning Rock Biotech Ltd.
Gross Profit Margin (TTM) N/A 60.34% N/A
Revenue per Share (TTM) $50 $35 Burning Rock Biotech Ltd.
Earnings per Share (Diluted) $-0.75 $5.16 Danaher Corporation
Beta (Stock Volatility) 1.60 0.99 Danaher Corporation
Short % of Float 0.87% 1.10% Burning Rock Biotech Ltd.

Burning Rock Biotech Ltd. vs Danaher Corporation Stock Performance Analysis

Loading Price Chart...

BNR
DHR

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Burning Rock Biotech Ltd.-9.85%-28.59%-49.45%-63.08%-61.80%-55.84%
Danaher Corporation1.12%2.86%2.32%-12.71%-22.05%-22.71%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Burning Rock Biotech Ltd.200.65%285.12%-65.34%-62.16%-62.16%-62.16%
Danaher Corporation-3.81%-12.18%-14.95%176.52%423.71%744.91%

Performance & Financial Health Analysis: Burning Rock Biotech Ltd. vs Danaher Corporation

MetricBNRDHR
Market Information
Market Cap i$221.68M$126.39B
Market Cap CategoryMicro capLarge cap
10 Day Avg. Volume i24,7225,174,666
90 Day Avg. Volume i31,6744,357,215
Last Close$8.69$178.08
52 Week Range$2.80 - $41.72$160.93 - $242.80
% from 52W High-79.17%-26.66%
All-Time High$41.69 (Jan 22, 2026)$296.06 (Sep 06, 2021)
% from All-Time High-79.16%-39.85%
Growth Metrics
Quarterly Revenue Growth0.00%0.04%
Quarterly Earnings GrowthN/A0.08%
Financial Health
Profit Margin (TTM) i-0.10%0.15%
Operating Margin (TTM) i-0.10%0.23%
Return on Equity (TTM) i-0.10%0.07%
Debt to Equity (MRQ) i8.0637.17
Cash & Liquidity
Book Value per Share (MRQ)$7.49$74.32
Cash per Share (MRQ)$4.57$8.06
Operating Cash Flow (TTM) i$-4,171,734$6.44B
Levered Free Cash Flow (TTM) i$-6,115,827$4.57B
Dividends
Last 12-Month Dividend Yield iN/A0.56%
Last 12-Month Dividend iN/A$1.28

Valuation & Enterprise Metrics Analysis: Burning Rock Biotech Ltd. vs Danaher Corporation

MetricBNR (Apr 24, 2026)DHR (Apr 24, 2026)
Price Ratios
P/E Ratio (TTM) i-0.6134.61
Forward P/E i-35.6019.64
PEG Ratio i0.013.84
Price to Sales (TTM) i0.415.10
Price to Book (MRQ) i2.762.40
Market Capitalization
Market Capitalization i$221.68M$126.39B
Enterprise Value i$253.48M$140.38B
Enterprise Value Metrics
Enterprise to Revenue i3.205.67
Enterprise to EBITDA i-499.7717.69
Risk & Other Metrics
Beta i1.600.99
Book Value per Share (MRQ) i$7.49$74.32

Financial Statements Comparison: Burning Rock Biotech Ltd. vs Danaher Corporation

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricBNR (2024)DHR (2025)
Revenue/Sales i515.82M24.57B
Cost of Goods Sold i153.42M10.05B
COGS % of Revenue i29.7%40.9%
Gross Profit i362.40M14.52B
Gross Margin i70.3%59.1%
Research & Development i232.29M1.60B
Operating Income (EBIT) i-322.43M4.69B
Operating Margin i-62.5%19.1%
EBITDA i-235.01M7.17B
EBITDA Margin i-45.6%29.2%
Pre-Tax Income i-340.74M4.23B
Pre-Tax Income % of Revenue i-66.1%17.2%
Income Tax i5.89M633.00M
Income Tax % of Revenue i1.1%2.6%
Net Income (Profit) i-346.63M3.61B
Profit Margin i-67.2%14.7%

Balance Sheet & Liquidity Metrics

MetricBNR (2024)DHR (2025)
Cash & Equivalents i519.85M4.62B
Total Current Assets i776.62M12.76B
Total Current Assets % of Revenue i150.6%51.9%
Total Current Liabilities i266.30M6.81B
Total Current Liabilities % of Revenue i51.6%27.7%
Long-Term Debt i27.75M19.50B
Long-Term Debt % of Revenue i5.4%79.4%
Total Shareholders Equity i580.83M52.54B
Retained Earnings i-4.20B46.89B
Retained Earnings % of Revenue i-814.3%190.9%
Property, Plant & Equipment i105.39M2.14B

Cash Flow Statement Comparison

MetricBNR (2024)DHR (2025)
Operating Cash Flow i-159.58M5.64B
Operating Cash Flow % of Revenue i-30.9%23.0%
Capital Expenditures i-3.85M-1.12B
Free Cash Flow i-98.24M5.26B
FCF Margin i-19.0%21.4%
Debt Repayment i0-500.00M
Common Stock Repurchase i-72,000-3.09B

Short Interest & Institutional Ownership Analysis

MetricBNRDHR
Shares Short i63,9466.94M
Short Ratio i1.931.68
Short % of Float i0.87%1.10%
Shares Outstanding i9.03M707.70M
Float Shares i44.05M630.65M
% Held by Insiders i3.92%10.78%
% Held by Institutions i44.73%85.08%
% Held by Public i51.35%4.14%

Dividend Analysis & Yield Comparison: Burning Rock Biotech Ltd. vs Danaher Corporation

MetricBNRDHR
Last 12-Month Dividend iN/A$1.28
Last 12-Month Dividend Yield iN/A0.56%
3-Year Avg Annual Dividend iN/A$10.51
3-Year Avg Dividend Yield iN/A1.11%
3-Year Total Dividends iN/A$31.54
Ex-Dividend DateN/ADec 26, 2025